Introduction
Hypertension is a major risk factor for the development of cardiovascular disease 1 and the benefits of reducing blood pressure in this condition are now well established. An important feature of hypertension is increased peripheral resistance, and considerable research has, therefore, focused on the structure and function of peripheral arterioles. The role of the larger arteries in the genesis and maintenance of hypertension has been largely ignored. Indeed, until recently large arteries were thought to function predominantly as passive conduits and to have little influence on blood pressure. However, mounting evidence suggests that pulse pressure, rather than systolic or diastolic pressure alone, is the most important predictor of cardiovascular risk. 2, 3 Pulse pressure is a surrogate measure of arterial stiffness and this has focused attention away from peripheral resistance and towards arterial stiffness, and in particular the interactions between the heart and the arterial tree. 4 Indeed, aortic stiffness is correlated with the severity of coronary artery disease at angiography. 5 Aging is associated with arterial stiffening, 6 as are a number of cardiovascular risk factors which cause premature vascular stiffening, including hypertension. 7 Type 2 diabetes mellitus is an important cardiovascular risk factor and is commonly associated with hypertension. The benefits of aggressive blood pressure reduction in preventing both micro-and macro-vascular disease in patients with type 2 diabetes have been demonstrated in the recent UKPDS Study. 8 Patients with type 2 diabetes also have increased left ventricular mass, itself an important and independent predictor of outcome, 9 compared with non-diabetic patients, even after correction for peripheral blood pressure. 10 Increased stiffness, augmenting central systolic pressure may explain this finding, and may provide one potential mechanism by which diabetes predisposes to cardiovascular disease. However, whether measurement of arterial stiffness will prove to be a better predictor of cardiovascular risk than simply assessing pulse pressure at the brachial artery remains unclear, and the results of large-scale outcome studies are awaited.
The large arteries
In addition to their role as conduits, the large arteries such as the aorta are compliant structures due to the presence of elastin, smooth muscle and collagen in the arterial wall 11 and serve to buffer the change in pressure resulting from intermittent ventricular ejection, thus smoothing peripheral blood flow. 12 The rate at which pressure waves travel along the arterial tree-the pulse wave velocity (PWV)-is, in part, determined by arterial wall stiffness. The forward-going pressure wave is reflected from sites of impedance mis-match in the peripheral circulation and normally returns to the aorta during diastole, serving to maintain coronary blood flow. 13 With age, arteries stiffen, increasing the PWV and the amplitude of the reflected pressure wave. Consequently, a larger reflected wave returns to the ascending aorta earlier and adds to, or augments, late systolic pressure. 6 The peripheral pressure waveform is relatively unaffected and so brachial artery pressure changes much less than central pressure.
11 Conventional sphygmomanometry will, therefore, underestimate the effect of arterial stiffening on central arterial pressure and provide less information concerning systemic arterial stiffness. This is important because it is central pressure that determines left ventricular workload; with higher pressure promoting left ventricular hypertrophy. Higher pressure also increases the risk of stroke, reduces shear stress, and accelerates arteriosclerosis, further stiffening the arterial tree and setting up a vicious circle. Thus, analysis of the central arterial pressure waveform provides more information concerning arterial stiffness and central blood pressure than conventional sphygmomanometry, and may lead to improved risk stratification.
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Pulse wave analysis
Arterial stiffness can be assessed using a variety of different techniques; each with particular advantages and disadvantages.
14 PWV can be measured non-invasively and provides useful information concerning the stiffness of the artery under study, since, all other parameters being equal, PWV is dependent upon vessel distensibility. Various ultrasound techniques for measuring vessel diameter, distensibility and compliance, have been widely applied, 14 and some are even independent of blood pressure. 15 However, such techniques are limited by the ability of the operator to accurately image the anterior and posterior walls of the vessel concerned, and are only easily applied to large, accessible arteries. Moreover, the accurate use of ultrasound requires specialised training, and the necessary equipment is often not easily transported. The limiting factor with all these techniques is that they only provide information about the stiffness of a single vessel or arterial segment. They do not provide information about systemic arterial stiffness or central arterial pressure. However, analysis of the arterial pressure wave contour, PWA, can provide such potentially useful information.
Pulse wave analysis and has been in clinical use for over 100 years, in a variety of guises. 16, 17 Until recently, however, only peripheral arterial waveforms could be recorded non-invasively, but refinements introduced by O'Rourke have made non-invasive analysis of central waveforms possible for the first time. 18 In the O'Rourke system peripheral pressure waveforms are recorded with high fidelity using applanation tonometry. 19 A tonometer, with a Millar micromanometer at its tip, is used to flatten but not occlude a peripheral artery. Circumferential pressures are equalised and accurate recording of the pressure waveform is obtained. This works best for peripheral arteries that can be easily compressed, such as the radial artery at the wrist. The peripheral waveform is then transformed into the corresponding central arterial waveform, using Fourier analysis, and a validated generalised transfer factor based on data obtained from invasive recordings. [20] [21] [22] [23] Augmentation index (AIx), a measure of systemic arterial stiffness, can then be calculated as the difference between the first and second systolic peaks expressed as a percentage of the pulse pressure, and central pressure derived. 18 Moreover, by gating measurements to the R wave of an ECG, and making recordings at two sites, PWV can also be measured. We have already shown that the system can be used reproducibly in various patient groups, 24 and believe that it provides an ideal tool with which to assess arterial stiffness easily and rapidly in large outcome-based studies. 25 PWA may also improve our understanding of the physiological mechanisms regulating arterial stiffness and be a useful method with which to assess the effect of drugs on the arterial tree.
Arterial stiffness and type 2 diabetes mellitus
Type 2 diabetes mellitus is associated with increased arterial stiffness at an early stage, even before clinically apparent atherosclerosis. 7 Increased aortic PWV has been described by both Wahlqvist 26 and Lehman 27 in otherwise healthy subjects with type 2 diabetes. Salomaa 28 and Emoto 29 have also reported increased carotid artery stiffness in this patient group. Furthermore, in the ARIC study, carotid artery stiffness was positively correlated with serum glucose concentration. 28 Emoto reported an inverse correlation between stiffness and insulin sensitivity, and a positive correlation between stiffness and duration of diabetes. Abnormalities of the brachial pressure waveform, consistent with increased peripheral arterial stiffness, can also be detected early in the course of type 2 diabetes before complications of the disease become apparent. 30 It is unlikely that atherosclerosis per se accounts for the arterial stiffening which characterises type 2 diabetes, as changes in arterial stiffness have also been reported in association with elevated plasma glucose, even before the onset of frank diabetes. 28 Indeed, aortic PWV is increased in young nondiabetic adults with a family history of type 2 diabetes. 31 Whether the changes in arterial stiffness in diabetes are simply a marker for occult atheroma, or are causally involved in atherogenesis, remains unclear. Moreover, the validity of measuring arterial stiffness in clinical practice remains to be firmly established.
Functional regulation of arterial stiffness
Whilst important, it is unlikely that physical structure alone determines arterial stiffness. A number of vasoactive substances including nitric oxide (NO) and endothelin (ET) are released from the vascular endothelium and there is accumulating evidence that such mediators can influence vascular stiffness; suggesting a degree of functional control. 32 This concept is supported by the observation that glyceryl trinitrate (GTN), an exogenous source of NO, profoundly alters the arterial pressure waveform and reduces AIx, without changing peripheral pressure. 33, 34 This is mainly due to reduced wave reflection, brought about by improved impedance mismatch at the site of wave reflection. Aortic compliance does not change greatly, but reduced stiffness of the muscular arteries is likely to contribute to some of the effects of GTN by reducing PWV. 11 Serum levels of ET, a potent vasoconstrictor, also correlate with an ultrasound-determined index of vascular stiffness, further supporting the concept of functional regulation. 35 We have recently shown that experimental endothelial dysfunction induced in healthy male volunteers by systemic infusion of the nitric oxide synthase inhibitor L-NMMA increases AIx.
36
Type 2 diabetes mellitus and endothelial dysfunction
Studies have directly investigated endothelial function in type 2 diabetes mellitus. McVeigh et al 37 reported decreased responses to acetylcholine and GTN in the forearm vascular bed. 37 These findings have been confirmed in a more recent study, 38 and suggest either impaired vascular smooth muscle sensitivity to NO or its increased inactivation. However, they support the concept of reduced functional activity of the vascular NO system in patients with type 2 diabetes mellitus.
The mechanism underlying these abnormalities is unclear but hyperglycaemia may be important. Indeed, Williams et al 39 have demonstrated impaired endothelial-dependent responses following induction of acute hyperglycaemia. Therefore, we studied changes in AIx following an acute oral glucose load of 75 g. Instead of increasing, as might be predicted if hyperglycaemia impaired endothelial function acutely in normal subjects, AIx actually fell significantly, 40 indicating that acute hyperglycaemia decreases vascular stiffness in healthy volunteers. One explanation for this observation is that insulin released in response to hyperglycaemia might be responsible for the reduction in arterial stiffness. It is, therefore, tempting to speculate that the increased stiffness found in subjects with type 2 diabetes may be due in part to insulin resistance. 41 
The effect of insulin of arterial stiffness
Insulin is a vasodilator peptide and increases skeletal muscle blood flow via a mechanism which is, in part, dependent on the release of NO from endothelial cells. 40 However, the effect of insulin on peripheral blood flow is only manifest following prolonged infusion, resulting in pharmacological concentrations of insulin, and is unlikely to be of physiological importance. 42 Westerbacka et al 43 have recently investigated the effect of insulin on forearm blood flow and arterial stiffness in healthy volunteers under normoglycaemic hyperinsulinaemic conditions using PWA. During the initial 120 min of insulin infusion there was no change in heart rate, peripheral systolic or diastolic blood pressure, forearm blood flow (FBF) or peripheral resistance. FBF did increase significantly, after a further 60 min when the infusion rate of insulin was increased. In contrast, AIx decreased significantly following 60 min of insulin infusion and was accompanied by a rise in plasma insulin, which remained within the physiological range. These data indicate that insulin does modulate arterial stiffness in healthy individuals. Coupled with the marked temporal dissociation between the effect of insulin on AIx and FBF, this suggests that insulin, at physiological concentrations, may act preferentially to dilate large arteries rather than arterioles. Westerbacka et al 44 went on to test the hypothesis that the effect of insulin on arterial stiffness would be reduced in individuals with insulin resistance by studying obese subjects. Under normoglycaemic hyperinsulinaemic conditions, whole body glucose uptake was reduced in the obese relative to nonobese subjects. Insulin significantly increased FBF in the non-obese subjects after 150 mins, but only after 240 mins in the obese subjects. In contrast to these slow changes in FBF, there was a significant decrease in AIx in the non-obese subjects within 60 mins, but no change in the obese subjects. Whole
Journal of Human Hypertension body glucose uptake and percentage fat correlated inversely with the effect of insulin on AIx. These data indicate that in obese subjects the effect of insulin on arterial stiffness is attenuated. This defect in insulin action on large vessel function provides one potential mechanism to explain the association of insulin resistance and macrovascular disease.
Summary
In order for PWA to become a clinically useful tool, large-scale studies need to be undertaken to ascertain whether arterial stiffness is a better predictor of cardiovascular morbidity and mortality than existing risk factors. 25 To this end, PWA has been included in three large-scale intervention studies to determine the effect therapeutic intervention has on central pressure and arterial stiffness in patients with three of the major cardiovascular risk factors: hypertension (ASCOT study); hypercholesterolaemia (SEARCH study) and type 2 diabetes (FIELD study). The results of these studies are awaited with interest. Meanwhile PWA offers the potential for better assessment of the response to drug therapy. Moreover, when combined with appropriate pharmacological stimuli PWA may provide a valuable non-invasive method for assessing endothelial function.
